Filing Details

Accession Number:
0001179110-16-028708
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-16 14:00:48
Reporting Period:
2016-08-15
Filing Date:
2016-08-16
Accepted Time:
2016-08-16 14:00:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1537768 A. Daniel Macuga 3838 West Parkway Blvd.
Salt Lake City UT 84120
Chief Communications Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-08-15 1,267 $57.62 1,267 No 4 M Direct
Common Stock Disposition 2016-08-15 1,267 $132.15 0 No 4 S Direct
Common Stock Acquisiton 2016-08-15 8,352 $57.62 8,352 No 4 M Direct
Common Stock Disposition 2016-08-15 8,352 $131.13 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Settled Stock Appreciation Rights Disposition 2016-08-15 2,249 $0.00 2,249 $57.62
Common Stock Stock Settled Stock Appreciation Rights Disposition 2016-08-15 15,001 $0.00 15,001 $57.62
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
32,251 2016-08-15 2018-03-15 No 4 M Direct
17,250 2016-08-15 2018-03-15 No 4 M Direct
Footnotes
  1. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights diisclosed in Table-II
  2. Weighted average price of $132.1487. Price range in multiple transaction was $132 to $132.53 inclusively.
  3. Weighted average price of $131.1301. Price range in multiple transaction was $130.885 to $131.6 inclusively.